{"title": "Estudio de preformulaci\u00f3n de una vacuna pentavalente de DPT-HB-Hib cubana, Heberpenta\u00ae-L", "author": "N\u0165stor S Exp\u016fsito-Raya; Yayr\u016a C Prieto-Correa; Mabel Izquierdo-L\u016fpez; Zoe Nu\u016eez-Lamothe; Soraya Piloto-D\u016aaz; Yamila Mart\u016anez-Cuellar; Makis Torres-Toledo; Annette Pereira-Sanabria; Rub\u0165n L\u016fpez-Edghill; Jose L Marcelo-Sainz; Amarilys Rodriguez-Arrebato; Mar\u016aa de los A Denis-Cruz; Yanet Alderete-Avalos; Anaelsi Chacon-Molina; Eduardo Mart\u016anez-D\u016aaz", "url": null, "hostname": null, "description": null, "sitename": "Biotecnolog\u016aa Aplicada", "date": "1999-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "2020, N\u00famero 1\nBiotecnol Apl 2020; 37 (1)\nEstudio de preformulaci\u016fn de una vacuna pentavalente de DPT-HB-Hib cubana, Heberpenta\u0123-L\n[ ](addFavorito.php?idArt=103949&idPub=9742)\nExp\u016fsito-Raya NS, Prieto-Correa YC, Izquierdo-L\u016fpez M, Nu\u016eez-Lamothe Z, Piloto-D\u016aaz S, Mart\u016anez-Cuellar Y, Torres-Toledo M, Pereira-Sanabria A, L\u016fpez-Edghill R, Marcelo-Sainz JL, Rodriguez-Arrebato A, Denis-Cruz MA, Alderete-Avalos Y, Chacon-Molina A, Mart\u016anez-D\u016aaz E\nIdioma: Ingles.\nReferencias bibliogr\u00e1ficas: 37\nPaginas: 1201-1209\nArchivo PDF: 391.46 Kb.\nRESUMEN\nEl desarrollo de vacunas combinadas es un proyecto muy \u0137til por todas las ventajas que ofrece este tipo de vacuna, sin embargo, no est\u0160 exento de complejidades en su ejecuci\u016fn debido a sus desaf\u016aos tecnol\u016fgicos. En Cuba se desarroll\u016f satisfactoriamente una vacuna pentavalente (DPT-HB-Hib), bajo la marca Heberpenta\u0123, que contiene cinco ant\u016agenos: anatoxina dift\u0165rica y tet\u0160nica, c\u0165lulas enteras de Bordetella pertussis, ant\u016ageno de superficie recombinante del virus de la hepatitis B y el polisac\u0160rido sint\u0165tico (polirribosil ribitol fosfato, PRP) de Haemophilus influenzae conjugado con anatoxina tet\u0160nica (PRP-T). Se realiz\u016f un estudio previo a la formulaci\u016fn utilizando una mezcla de adyuvantes que definen el tiempo de absorci\u016fn \u016fptimo para cada ant\u016ageno. Se formularon tres lotes a escala piloto con la tecnolog\u016aa definida y se estudiaron utilizando diferentes pruebas f\u016asico-qu\u016amicas y biol\u016fgicas. La tecnolog\u016aa para la formulaci\u016fn de la vacuna pentavalente producida en Cuba se defini\u016f de acuerdo con estos resultados, que luego deben someterse a estabilidad, estudios no cl\u016anicos y cl\u016anicos.\nREFERENCIAS (EN ESTE ART\u00cdCULO)\nSkibinski DAG, Baudner BC, Singh M, O\u00edHagan DT. Combination vaccines. J Global Infect Dis. 2011;3(1):63-72.\nMarshall GS, Happe LE, Lunacsek OE, Szymanski MD, Woods CR, Zahn M, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26:496-500.\nKalies H, Grote V, Verstraeten T, Hessel L, Schmitt HJ, von Kries R. The use of combination vaccines has improved timeliness of vaccination in children. Pediatr Infect Dis J. 2006;25:507-12.\nWeston WM, Klein NP. Kinrix: A new combination DTaPIPV vaccine for children aged 46 years. Expert Rev Vaccines. 2008;7:1309-20.\nBogaerts H. The future of childhood immunizations: Examining the European experience. Am J Manag Care. 2003;9:S30-6.\nPetre J, Hauser P, inventors; Glaxo- SmithKline Biologicals S.A., assignee. Combined vaccines comprising hepatitis B surface antigens and other vaccines. EP 0835663B1. 1993 May 15.\nJones LTS, Peek LJ, Power J, Markham A, Yazzie B, Middaugh CR. Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens. J Biol Chem. 2005;280(14):13406- 14.\nMatheis W, Zott A, Schwanig M. The role of the adsorption process for production and control combined adsorbed vaccines. Vaccine. 2001;20(1-2):67-73.\nRamon G. Floculation dans un \u0165lange neutre de toxin-antitoxine dipht\u0165riques. CR Soc Biol. 1922;86:6.\nWorld Health Organization. Manual for the Production and Control of Vaccines: Tetanus Toxoid. Geneva: WHO; 1978.\nGonz\u0160lez-Griego A, Alerm A, Vega I, Ram\u016arez V, Salgado A, Vingut JL. Cuantificaci\u016fn del ant\u016ageno de superficie del VHB (HBsAg) en muestras biol\u016fgicas con fines asistenciales y preparativos. Biotecnol Apl. 1993;10(2):10.\nBritish Pharmacopoeia. London: Her Majesty\u00eds Stationery Office; 2004.\nUnited States Pharmacopoeia 30. National Formulary 25. United States Pharmacopoeia Convention; Inc.: Rockville, MD; 2007.\nPPO 4.09.064.92. Determinaci\u016fn de la concentraci\u016fn de i\u016fn aluminio por Complejometr\u016aa. La Habana: CIGB; 1999.\nCIGB. PPO 4.09.062.92. Espectrofotometr\u016aa m\u0165todo utilizado por el fabricante (CIGB) para la cuantificaci\u016fn de Tiomersal en las vacunas monovalentes y combinadas. La Habana: CIGB; 1992.\nBioCen. PNO 07.154, Determinaci\u016fn de la toxicidad espec\u016afica de las anatoxinas dift\u0165rica y tet\u0160nica en la vacuna pentavalente DPT-HB-Hib, Heberpenta-L. La Habana: BioCen; 2009.\nBioCen. PNO 07.155, Determinaci\u016fn de la toxicidad espec\u016afica de la Bordetella pertussis en la vacuna pentavalente DPT-HB-Hib, Heberpenta-L. La Habana: BioCen; 2009.\nGonz\u0160lez P, Mart\u016anez S, Ram\u016arez JC, Dom\u016anguez F, D\u016aaz Y, Ram\u016arez U, et al. Vacuna antidift\u0165rica-tet\u0160nica y antidift\u0165ricatet\u0160nica- pertussis: evaluaci\u016fn del producto final. VacciMonitor. 1999;8(2):8-12.\nCIGB. PPO.4.09.093.04. Procedimiento para la determinaci\u016fn de la identidad del AgsHB utilizando el sistema ELISA en vacunas. La Habana: CIGB; 2013.\nCIGB. PPO.4.09.041.03. Procedimiento para la determinaci\u016fn de la identidad del PRP-T utilizando el m\u0165todo de inmunoidentificaci\u016fn por Latex en vacunas. La Habana: CIGB; 2008.\nFitzgerald EA. Overview of the methods for potency testing of diphtheria and tetanus toxoids in the United States. In: Manclark CR (ed). Proceedings of an Informal Consultation on the World Health Organization Requirements for Diphtheria, Tetanus, Pertussis and Combined Vaccines. Department of Health and Human Services, United States Public Health Service. Bethesda, MD, DHHS Publication No. (FDA) 91-1174; 1991. pp 61-4.\nFinney D J. Probit Analysis. 3rd edition. New York: Cambridge University Press; 1971.\nWorld Health Organization. Manual of laboratory methods for testing of vaccines used in the WHO Expanded Programme on Inmunization. Global programme for vaccines and inmunization. Vaccine supply and quality. Assay for testing the potency of whole cell pertussis vaccines in monovalent or combined form. Geneva: WHO; 1997.\nCIGB. PPO 4.09.060.92. Edici\u016fn 09. Procedimiento establecido para la determinaci\u016fn de la potencia in vivo de la vacuna la hepatitis B recombinante y vacunas combinadas que contengan como componente activo el AgsHB. La Habana: CIGB; 2008.\nCIGB. PPO 4.09.037.03. Procedimiento para la determinaci\u016fn de la inmunogenicidad del componente PRP-T en vacunas. La Habana: CIGB; 2013.\nBaylor NW, Egan W, Richman P. Aluminum salts in vaccines--US perspective. Vaccine. 2002; 20 Suppl 3:S18-23.\nKool M, Fierens K, Lambrecht BN. Alum adjuvant: some of the tricks of the oldest adjuvant. J Med Microbiol. 2012;61:927-34.\nGupta RK, Rost BE, Relyveld E, Siber GR. Adjuvant properties of aluminium and calcium compounds. In: Powell MF, Newman MJ, editors. Vaccine design: the subunit and adjuvant approach. New York: Plenum Press; 1995. p. 229-48.\nWalls RS. Eosinophil response to alum adjuvants: Involvement of T cells in nonantigen- dependent mechanisms. Proc Soc Exp Biol Med. 1977;156:431-5.\nRappuoli R. New and improved vaccines against diphteria and tetanus. In: Woodrow GC, Levine MM. (eds), New Generation Vaccines. New York: Marcel Dekker; 1990. pp. 251.\nLatham WC, Bent DF, Levine L. Tetanus toxin production in the absence of protein. Appl Environ Microbiol. 1962;10(2): 146-52.\nOrganizaci\u016fn Mundial de la Salud. Gu\u016aa de la OMS sobre los requisitos de las pr\u0160cticas adecuadas de fabricaci\u016fn (PAF). Segunda parte: Validaci\u016fn. WHO/ VSQ/97.02. Geneva: OMS; 1998.\nLiu J, Feldkamp JL, White JL, Hem SL. Adsorption of phosphate by aluminum hydroxycarbonate. J Pharm Sci. 1984;73:1355-8.\nBleam WF, Pfeffer PE, Goldberg S, Taylor RW, Dudley RA. 31p solid-state nuclear magnetic resonance study of phosphate adsorption at the boehmite/aqueous solution interface. Langmuir. 1991;7:1702-12.\nIyer S, Robinett RS, HogenEsch H, Hem SL. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant. Vaccine. 2004;22:1475-9.\nSturgess AW, Rush K, Charbonneau RJ, Lee JI, West DJ, Sitrin RD, et al. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerisation of PRP in the presence of aluminium hydroxide. Vaccine, 1999;17(9-10):1169-78.\nGilchrist M Jr. Bordetella. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ (eds). Manual of clinical microbiology, 5th ed. Washington DC: American Society for Microbiology; 1991. pp. 471-7.", "language": null, "image": null, "pagetype": null, "links": ["https://www.medigraphic.com/", "resumenI.cgi?IDARTICULO=103949", "#", "https://www.medigraphic.com/cgi-bin/new/publicaciones.cgi?IDREVISTA=281", "https://www.medigraphic.com/cgi-bin/new/contenido.cgi?IDPUBLICACION=9742", "https://www.medigraphic.com/cgi-bin/new/publicaciones.cgi?IDREVISTA=281", "#", "https://www.medigraphic.com/cgi-bin/new/informacion.cgi?IDREVISTA=281", "https://www.medigraphic.com/cgi-bin/new/directorio.cgi?IDREVISTA=281", "#", "https://www.medigraphic.com/cgi-bin/new/instrucciones.cgi?IDREVISTA=281", "https://www.medigraphic.com/", "https://www.medigraphic.com/", "https://www.medigraphic.com/cgi-bin/new/medigraphic.cgi", "#", "#", "#", "#", "addFavorito.php?idArt=103949&idPub=9742", "https://www.medigraphic.com/pdfs/biotecapl/ba-2020/ba201a.pdf", "#", null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null, null]}